Matthew Hamilton Rosenberg’s Avanos Medical AVNS Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-19	Closed	-$375	–	835
2024 Q2	$375	Hold	19	–	–	﹤0.01%	771
2024 Q1	$372	Sell	19 -18	-49%	-$348	﹤0.01%	813
2023 Q4	$830	Hold	37	–	–	﹤0.01%	799
2023 Q3	$748	Buy	37 +18	+95%	+$408	﹤0.01%	799
2023 Q2	$486	Hold	19	–	–	﹤0.01%	844
2023 Q1	$565	Hold	19	–	–	﹤0.01%	869
2022 Q4	$514	Buy	+19	New	+$465	﹤0.01%	867
2022 Q3	–	Sell	-19	Closed	-$1K	–	856
2022 Q2	$1K	Hold	19	–	–	﹤0.01%	766
2022 Q1	$1K	Hold	19	–	–	﹤0.01%	728
2021 Q4	$1K	Hold	19	–	–	﹤0.01%	703
2021 Q3	$1K	Hold	19	–	–	﹤0.01%	672
2021 Q2	$1K	Hold	19	–	–	﹤0.01%	575
2021 Q1	$1K	Hold	19	–	–	﹤0.01%	545
2020 Q4	$1K	Hold	19	–	–	﹤0.01%	529
2020 Q3	$1K	Hold	19	–	–	﹤0.01%	520
2020 Q2	$1K	Buy	+19	New	+$550	﹤0.01%	539

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Matthew Hamilton Rosenberg's AVNS Position: Q3 2024 in Review

Matthew Hamilton Rosenberg sold out of Avanos Medical (AVNS) in Q3 2024, closing a stake of 19 shares — an estimated $375 sold.

Matthew Hamilton Rosenberg first reported a position in AVNS in Q2 2020 and held it in 16 quarters. The position peaked at $1K in Q2 2022. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

Matthew Hamilton Rosenberg reported no remaining Avanos Medical position as of Q3 2024 after selling out during the quarter.
Matthew Hamilton Rosenberg sold 19 Avanos Medical shares in Q3 2024, an estimated $375.
Matthew Hamilton Rosenberg first reported a position in Avanos Medical in Q2 2020 and held it in 16 quarters.
Matthew Hamilton Rosenberg's Avanos Medical position peaked at $1K in Q2 2022.
260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2024, filed 28 Oct 2024.